Boule Diagnostics AB (publ) / Fundamentals
Income statement
- Net revenue
€47.19M - Cost of goods sold
€26.28M - Gross profit
€20.91M - SG&A expenses
€12.75M - R&D expenses
€29.52M - EBITDA
-€24.39M - D&A
€1.02M - EBIT
-€25.08M - Interest expenses
€1.21M - EBT
-€26.91M - Tax expenses
-€4.27M - Net income
-€22.63M
Cash flow statement
- Net deferred tax
€0.00 - Non-cash items
€27.94M - Changes in working capital
-€1.44M - Operating cash flow
€896.25K - Capex
€3.69M - Other investing cash flow
-€3.11M - Net investing cash flow
-€3.69M - Total cash dividends paid
€0.00 - Issuance of common stock
€0.00 - Debt repayment
€1.55M - Other financing cash flow
€438.98K - Net financing cash flow
€1.98M - Foreign exchange effects
-€219.49K - Net change in cash
-€823.08K - Cash at end of period
€2.10M - Free cash flow
€4.58M
Balance sheet
- Cash and cash equivalents
€2.10M - Cash and short-term investments
€2.10M - Total receivables
€12.90M - Inventory
€6.06M - Other current assets
€457.27K - Total current assets
€21.53M - Property, plant & equipment
€2.62M - Goodwill
€7.49M - Intangible assets
€475.56K - Long-term investments
€3.79M - Other non-current assets
€0.00 - Total non-current assets
€21.03M - Total assets
€42.56M - Accounts payable
€2.73M - Short-term debt
€12.71M - Other current liabilities
€5.10M - Total current liabilities
€21.03M - Long-term debt
€6.28M - Deferred tax liabilities
€237.78K - Other non-current liabilities
€237.78K - Total non-current liabilities
€6.76M - Total liabilities
€27.79M - Common stock
€887.10K - Retained earnings
-€19.47M - Other equity
€2.61M - Total equity
€14.77M - Total liabilities and shareholders' equity
€42.56M
Company information
- Market capitalization
€31.30M - Employees
200 - Enterprise Value
€506.12M
Company ratios
- Gross margin
-
44.3% Much worse than peer group: 71.4% - EBITDA margin
-
-51.7% Much worse than peer group: 12.5% - EBIT margin
-
-53.1% Much worse than peer group: 3.8% - EBT margin
-
-57.0% Much worse than peer group: 3.6% - Net margin
-
-48.0% Much worse than peer group: 1.4% - ROE
-
-153.3% Much worse than peer group: 10.9% - ROA
-
-53.2% Much worse than peer group: 8.9% - Asset turnover
-
110.9% Much better than peer group: 80.2% - FCF margin
-
-5.9% Worse than peer group: 2.9% - FCF yield
-8.9% - Efficiency ratio
151.7% - Net sales per employee
-
€235.95K - Net income per employee
-
-€113.17K